Scientific articles published by the researchers of Barcelonaβeta Brain Research Center (BBRC), related to Alzheimer's disease, neuroimaging, memory and neurodegenerative diseases, among other fields.
Soldevila-Domenech N, Ayala-Garcia A, Zhou X, Yi SY, Ros E, Sala-Vila A, Lehtisalo J, Steffen LM, de la Torre R; IAFNS Retrospective Harmonization Expert Working Group; Blackwell CK, Khoo C, Mansolf MA, Ros E, Snetselaar L, Wey T.
Background: Cognitive decline is a major public health concern as populations age. Diet is a modifiable contributor to cognitive health, yet observational findings remain inconsistent, partly due to...
Gallay C, Soldevila-Domenech N, López-Martos D, Sanchez-Benávides G, Huguet J, Suárez-Calvet M, Gispert JD, Salvadó G, Sundermann EE, Grau-Rivera O, Brugulat-Serrat A; for ALFA study.
Background and objectives: Epidemiologic studies exploring the effect of parity on Alzheimer disease (AD) yield mixed results, and little is known about how parity may modify the impact of AD...
López-Martos D, Suárez-Calvet M, Salvadó G, Cacciaglia R, Shekari M, González-Escalante A, Horta-Barba A, Palma-Gudiel H, Milà-Alomà M, Brugulat-Serrat A, Minguillon C, Tonietto M, Borroni E, Klein G, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Gispert JD, Sánchez-Benavides G, Grau-Rivera O; ALFA study.
Alzheimer's disease (AD) diagnostic guidelines emphasize subjective cognitive decline (SCD) preceding mild cognitive impairment (MCI), implicitly assuming awareness of cognitive decline (ACD) is...
Contador J, Pozzi FE, Sánchez-Benavides G, Fernández-Arcos A, Lantero-Rodríguez J, Montoliu-Gaya L, Minguillon C, Fauria K, González-Escalante A, Ortiz-Romero P, Blasco-Forniés H, de Diego-Osaba M, Jiménez Moyano E, Quijano-Rubio C, Kollmorgen G, Le Bastard N, Nadal A, Vanmechelen E, Jeromin A, Torres-Torronteras J, Ashton NJ, Zetterberg H, Blennow K, Gispert JD, Molinuevo JL, Del Campo M, Grau-Rivera O, Suárez-Calvet M; β-AARC Study collaborators.
Background: Subjective cognitive decline (SCD) may represent an early stage of Alzheimer's disease (AD), but biomarker studies in this population are limited. Therefore, we compared the performance of...
López-Martos D, Cacciaglia R, Suárez-Calvet M, Salvadó G, Shekari M, González-Escalante A, Milà-Alomà M, Brugulat-Serrat A, Minguillon C, Tonietto M, Borroni E, Klein G, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Blennow K, Gispert JD, Grau-Rivera O, Sánchez-Benavides G; ALFA study.
Background: The objective of this study was to provide a multimodal biomarker characterization of amnestic objective subtle cognitive decline (obj-SCD) in aging and preclinical Alzheimer's disease (AD...
Manzano Palomo MS, Terrón Cuadrado C, Gil Moreno MJ, Fernández García C, Alonso Bouzón C, Besga Basterra A, Brugulat-Serrat A, Teresa Carreras M, Castellanos Rodrigo M, Delgado Parada E, García Ribas G, Gramunt Fombuena N, Millán Pacheco A, Pagonabarraga Mora J, Porta Etessam J, Ramírez Díaz SP, Isabel Ramos García M, Rodríguez-Sánchez I, Salas Carrillo M, Sánchez-Benavides G, Simal Hernández P, Vieira Campos A.
Introduction: The onset of mild functional impairment (MFI) is associated with greater progression to cognitive decline, in addition to influencing the course of other neurological, psychiatric, and...
König A, Tröger J, Mallick E, Linz N, Ritchie C, Gregory S, Hunter M, Johnson K, Benavides GS, Grau-Rivera O, Radoi A, Porta-Mas C, Köhler S, Teipel S, Hansson O, Tideman P, Wuestefeld A, Palmqvist S.
Introduction: Early detection of Alzheimer's disease (AD) is critical for timely intervention as disease-modifying treatments emerge. Speech-based digital biomarkers offer scalable options for...
Fernández-Lebrero A, Jiménez-Balado J, García-Escobar G, Contador J, Estraguès-Gázquez I, Peraferrer-Montesinos L, Suárez-Pérez A, Manero-Borràs RM, Beltrán B, Gramegna L, Campello AR, Palacio-Gili A, Grau O, Suárez-Calvet M, Ois A, Puig-Pijoan A, Navalpotro-Gómez I.
Background: Cerebral amyloid angiopathy (CAA) frequently co-occurs with Alzheimer's disease (AD), complicating diagnosis in patients with cognitive impairment. The CSF biomarker profile of CAA remains...
Carmichael OT, Agarwal P, Albensi BC, Balendra V, D'Cunha NM, Denier-Fields DN, Ferreira NV, Gomes Gonçalves N, Kumar R, Labyak C, Lopez S, Lourenco MV, Lourida I, Nag R, Nedelska Z, Olayinka JN, Park JH, Rajendran K, Shaw A, Shrestha HL, Smith AN, Soldevila-Domenech N, Souza DG, Suemoto CK, Titiner JR, de la Torre R, van Lent DM.
Ultraprocessed foods (UPFs), which feature reductions in naturally occurring food components (fiber, phytochemicals) as well as the addition of fat, sugar, salt, and artificial food components...
Pérez-Enríquez C, García-Escobar G, Fernández-Lozano MP, Manero RM, Peña-Casanova J, Sánchez-Benavides G
Objective: The present study aims to provide Spanish normative data for the Reading the Mind in the Eyes Test (RMET) in a Spanish adult population.
Method: The normative sample consisted of 167...